Newswire (Published: Monday, January 9, 2017, Received: Friday, January 6, 2017, 12:09:25 PM CST)

Word Count: 308

Studies from National Cancer Institute Add New Findings in the Area of Prostate Cancer (The evolving role of enzalutamide on the treatment of prostate cancer)

By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting originating from Bethesda, Maryland, by NewsRx correspondents, research stated, "The field of prostate cancer has witnessed incredible progress in the last decade, owing to the approval of multiple survival-prolonging treatments for metastatic castration-resistant prostate cancer (mCRPC). Enzalutamide is a nonsteroidal androgen receptor inhibitor that targets multiple steps in the androgen receptor signaling axis."

Our news editors obtained a quote from the research from National Cancer Institute, "It has been approved for the treatment of mCRPC both in the postdocetaxel and in the chemotherapy-naive settings. We summarize the milestones in the development of enzalutamide in patients with prostate cancer."

According to the news editors, the research concluded: "Special focus is placed on the results of the STRIVE Phase II clinical trial comparing head to head enzalutamide and bicalutamide in patients with nonmetastatic and mCRPC who have failed androgen deprivation and in other ongoing trials in the same setting and in earlier disease phases."

For more information on this research see: The evolving role of enzalutamide on the treatment of prostate cancer. Future Oncology, 2016;12(5):607-16 (see also Oncology - Prostate Cancer).

The news editors report that additional information may be obtained by contacting R. Nadal, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Keywords for this news article include: Bethesda, Maryland, Oncology, United States, Article Review, Prostate Cancer, Prostatic Neoplasms, North and Central America.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

National Cancer Institute
National Institutes of Health

Places

Central America
North America
United States
Americas
Maryland
Bethesda

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Treatments and Therapies
            Chemotherapy